Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.
- DOI
- 10.3390/cancers18010076
- Published
- 2025 Dec 25
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18010076,
title = {Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.},
author = {Pina-Cabral T and Pereira J and Paulo-Fernandes J and Silva M and Fontes-Sousa M and Anacleto M and Lobo-Martins S and Mirco A and Miranda H and Martins A and Cavaco P},
year = {2025},
journal = {Cancers},
doi = {10.3390/cancers18010076},
url = {https://doi.org/10.3390/cancers18010076}
}RIS
TY - JOUR TI - Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance. AU - Pina-Cabral T AU - Pereira J AU - Paulo-Fernandes J AU - Silva M AU - Fontes-Sousa M AU - Anacleto M AU - Lobo-Martins S AU - Mirco A AU - Miranda H AU - Martins A AU - Cavaco P PY - 2025 JO - Cancers DO - 10.3390/cancers18010076 UR - https://doi.org/10.3390/cancers18010076 ER -
APA
T, P., J, P., J, P., M, S., M, F., M, A., S, L., A, M., H, M., A, M., & P, C. (2025). Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.. Cancers. https://doi.org/10.3390/cancers18010076
Source records
- pubmed · retrieved 2026-09-25T10:46:06.995Z